Increasing interest in PK and PD studies has many advantages for anesthesiologists.
作者信息
Woo Young-Cheol
机构信息
Department of Anesthesiology and Pain Medicine, Chung-Ang University Hospital, Seoul, Korea.
出版信息
Korean J Anesthesiol. 2011 Mar;60(3):149-50. doi: 10.4097/kjae.2011.60.3.149. Epub 2011 Mar 30.
Abstract
摘要
相似文献
1
Increasing interest in PK and PD studies has many advantages for anesthesiologists.
Korean J Anesthesiol. 2011 Mar;60(3):149-50. doi: 10.4097/kjae.2011.60.3.149. Epub 2011 Mar 30.
2
A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
Hum Reprod. 2017 Aug 1;32(8):1639-1647. doi: 10.1093/humrep/dex220.
3
Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
J Vet Pharmacol Ther. 2004 Dec;27(6):467-77. doi: 10.1111/j.1365-2885.2004.00613.x.
4
Application of microdialysis for pharmacokinetic-pharmacodynamic modelling.
Expert Opin Drug Discov. 2006 Sep;1(4):289-301. doi: 10.1517/17460441.1.4.289.
5
Microdialysis for pharmacokinetic-pharmacodynamic studies.
Pharmazie. 2007 Dec;62(12):883-91.
6
PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedside.
J Pharmacokinet Pharmacodyn. 2017 Apr;44(2):161-177. doi: 10.1007/s10928-017-9518-0. Epub 2017 Mar 28.
7
PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
J Vet Pharmacol Ther. 2004 Dec;27(6):491-502. doi: 10.1111/j.1365-2885.2004.00618.x.
8
Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions.
Pharmaceutics. 2021 Mar 21;13(3):422. doi: 10.3390/pharmaceutics13030422.
9
Volterra series in pharmacokinetics and pharmacodynamics.
J Pharmacokinet Pharmacodyn. 2003 Oct;30(5):337-62. doi: 10.1023/b:jopa.0000008158.30235.59.
10
Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
J Vet Pharmacol Ther. 2004 Dec;27(6):479-90. doi: 10.1111/j.1365-2885.2004.00617.x.
本文引用的文献
1
The BIS and hemodynamic changes in major burn patients according to a slow infusion of propofol for induction.
Korean J Anesthesiol. 2011 Mar;60(3):161-6. doi: 10.4097/kjae.2011.60.3.161. Epub 2011 Mar 30.
2
Early drug distribution: a generally neglected aspect of pharmacokinetics of particular relevance to intravenously administered anesthetic agents.
Clin Pharmacol Ther. 2008 Jul;84(1):18-22. doi: 10.1038/clpt.2008.107.
3
Anesthesia: a discipline that incorporates clinical pharmacology across the DDRU continuum.
Clin Pharmacol Ther. 2008 Jul;84(1):3-6. doi: 10.1038/clpt.2008.99.
4
Contributions of PK/PD modeling to intravenous anesthesia.
Clin Pharmacol Ther. 2008 Jul;84(1):27-38. doi: 10.1038/clpt.2008.100. Epub 2008 May 7.
5
Pharmacokinetics and pharmacodynamics of intravenously administered anesthetic drugs: concepts and lessons for drug development.
Clin Pharmacol Ther. 2008 Jul;84(1):153-7. doi: 10.1038/clpt.2008.80. Epub 2008 May 7.
6
Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion.
Anesthesiology. 2007 May;106(5):924-34. doi: 10.1097/01.anes.0000265151.78943.af.
7
The fate of thiopental in man and a method for its estimation in biological material.
J Pharmacol Exp Ther. 1950 Jan;98(1):85-96.
8
Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.
Clin Pharmacol Ther. 1979 Mar;25(3):358-71. doi: 10.1002/cpt1979253358.
9
A pharmacodynamic model for pancuronium.
Br J Anaesth. 1978 Nov;50(11):1113-23. doi: 10.1093/bja/50.11.1113.
Zotero 插件